| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |